Catalent, Inc.

10-K & 10-Q Filings

Catalent, Inc. is a global provider of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. The company's strategic ambition is to power the innovation and growth of the life science industry by becoming the leading development and commercial partner in reliable supply, conventional and advanced technologies, first-to-scale innovation, and therapeutic modalities. Catalent has a diverse range of offerings and serves a broad customer base, including 87 of the top 100 branded drug and consumer health marketers and 82 of the top 100 biologics marketers. The company's business segments include biologics, branded drugs, generic prescription drugs, over-the-counter drugs, and consumer health and other. Catalent's website is catalent.com, and its ticker symbol is CTLT on the New York Stock Exchange.

12 mos ending Jun 30, 201412 mos ending Jun 30, 201512 mos ending Jun 30, 201612 mos ending Jun 30, 201712 mos ending Jun 30, 201812 mos ending Jun 30, 201912 mos ending Jun 30, 202012 mos ending Jun 30, 202212 mos ending Jun 30, 20239 mos ending Mar 31, 20239 mos ending Mar 31, 2024CAGR %YoY %Revenue (+)
$1664.60
1725.80
1759.60
1985.30
2352.00
2518.00
3094.30
4828.00
4263.00
3208.00
3080.00
12.47%-3.99%Cost of Revenue (-)
$1066.00
1110.50
1260.50
1420.80
1710.80
1712.90
2111.00
3188.00
3223.00
2383.00
2511.00
14.83%5.37%Gross Profit (+)
$598.60
615.30
587.60
654.60
752.60
805.10
983.30
1640.00
1040.00
825.00
569.00
7.15%-31.03%Selling, General & Administrative (-)
$334.80
337.30
358.10
402.60
462.60
512.00
577.90
844.00
829.00
612.00
669.00
12.00%9.31%Non-recurring Operating Expenses (-)
$19.70
13.40
9.00
8.00
10.20
14.10
5.50
210.00
210.00
687.00
34.42%227.14%Operating Expenses (-)
$357.70
355.40
369.80
420.40
481.50
531.20
588.90
885.00
1203.00
862.00
1424.00
16.37%65.20%Costs & Expenses (Total) (-)
$1586.80
1570.90
1630.30
1841.20
2192.30
2244.10
2699.90
4073.00
4426.00
3245.00
3935.00
13.68%21.26%Operating Income/Loss (+)
$240.90
259.90
217.80
234.20
271.10
273.90
394.40
756.00
-163.00
-37.00
-855.00
-2210.81%Non-operating Income/Expense (+)
$-10.40
-42.40
15.60
-8.50
-7.70
-2.70
-7.90
-27.00
7.00
2.00
-21.00
-1150.00%Earnings before Tax (+)
$67.40
112.50
144.90
135.60
152.00
160.30
260.40
605.00
-342.00
-165.00
-1065.00
-545.45%Tax Expense (-)
$49.50
-97.70
33.70
25.80
68.40
22.90
39.70
86.00
-86.00
-19.00
1.00
105.26%Income/Loss (Continuing Operations) (+)
$17.90
210.20
111.20
109.80
83.60
137.40
220.70
519.00
-256.00
-146.00
-1066.00
-630.14%Income/Loss (Discontinued Operations) (+)
$-2.70
0.10
Profit/Loss (+)
$15.20
210.30
111.20
109.80
Net Income/Loss (NCI) (-)
$-1.00
-1.90
-0.30
Net Income/Loss (+)
$16.20
212.20
111.50
109.80
83.60
137.40
220.70
519.00
-256.00
-146.00
-1066.00
-630.14%Net Income/Loss (Common) (+)
$16.20
212.20
111.50
109.80
83.60
137.40
173.00
503.00
-256.00
-146.00
-1066.00
-630.14%EPS (Basic)
$0.22
1.77
0.89
0.88
0.64
0.92
1.16
2.85
-1.42
-0.81
-5.87
-624.69%EPS (Diluted)
$0.21
1.75
0.89
0.87
0.63
0.90
1.14
2.84
-1.42
-0.81
-5.87
-624.69%Weighted Avg Shares (Basic)
117.32
124.52
124.74
125.18
144.87
146.02
164.14
179.90
180.64
180.27
180.98
5.54%0.39%Cash
$74.40
151.30
131.60
288.30
410.20
345.40
953.20
449.00
280.00
252.00
162.00
18.02%-35.71%Receivables
$403.70
372.40
414.80
488.80
555.80
716.40
838.10
1051.00
1002.00
1049.00
875.00
12.03%-16.59%Inventory
$134.80
132.90
154.80
184.90
209.10
257.20
323.80
702.00
777.00
744.00
742.00
24.48%-0.27%Prepaid Expenses (Current)
$74.60
80.90
89.00
97.80
65.20
76.80
177.90
625.00
633.00
693.00
744.00
30.64%7.36%Other Assets (Current)
$
89.00
2917.00
2917.00
0.00%Assets (Current)
$687.50
737.50
790.20
1059.80
1240.30
1395.80
2293.00
2916.00
2692.00
5655.00
5440.00
18.60%-3.80%Securities & Long-term Investments
$
89.00
Property, Plant & Equipment (Net)
$873.00
885.20
905.80
995.90
1270.60
1536.70
1900.80
3127.00
3682.00
3671.00
3735.00
19.71%1.74%Goodwill & Intangibles
$1454.70
1430.20
1290.50
1317.20
1942.10
3151.70
3359.30
4066.00
4019.00
4035.00
3214.00
13.55%-20.35%Other Assets
$75.00
92.50
104.60
81.40
78.10
99.80
223.40
398.00
384.00
7977.00
7998.00
22.65%0.26%Assets (Non-current)
$2402.70
2407.90
2300.90
2394.50
3290.80
4788.20
5483.50
7680.00
8085.00
15683.00
14947.00
16.38%-4.69%Assets (Total)
$3090.20
3145.40
3091.10
3454.30
4531.10
6184.00
7776.50
10507.00
10777.00
21338.00
20387.00
16.90%-4.46%Accounts Payable
$148.10
128.20
143.70
163.20
192.10
255.80
321.00
421.00
424.00
394.00
377.00
14.05%-4.31%Debt (Current)
$25.20
23.80
27.70
24.60
71.90
76.50
72.90
31.00
536.00
588.00
47.00
46.54%-92.01%Other Liabilities (Current)
$279.70
247.00
219.80
281.20
312.90
338.40
499.30
620.00
570.00
1603.00
1681.00
9.31%4.87%Liabilities (Current)
$453.00
399.00
391.20
469.00
576.90
670.70
893.20
1072.00
1530.00
2585.00
2105.00
16.43%-18.57%Debt (Non-current)
$2685.40
1864.10
1832.80
2055.10
2649.40
2882.80
2945.10
4171.00
4313.00
4261.00
4933.00
6.10%15.77%Other Liabilities
$319.10
242.50
231.20
206.70
218.10
948.90
1039.40
469.00
323.00
5014.00
4963.00
0.15%-1.02%Liabilities (Non-current)
$3004.50
2106.60
2064.00
2261.80
2867.50
3831.70
3984.50
4640.00
4636.00
9275.00
9896.00
5.57%6.70%Liabilities (Total)
$3457.50
2505.60
2455.20
2730.80
3444.40
4502.40
4877.70
5712.00
6166.00
11860.00
12001.00
7.50%1.19%Retained Earnings
$-1379.10
-1166.90
-1036.10
-955.70
-872.10
-723.40
-535.20
538.00
262.00
890.00
-286.00
-132.13%AOCI
$-24.20
-174.00
-305.70
-314.10
-325.80
-353.90
-386.30
-394.00
-354.00
-368.00
-356.00
3.26%Shareholder's Equity
$-371.80
634.00
635.90
723.50
1086.70
1681.60
2898.80
4795.00
4611.00
9478.00
8386.00
-11.52%Liabilities & Equity
$3090.20
3145.40
3091.10
3454.30
4531.10
6184.00
7776.50
10507.00
10777.00
21338.00
20387.00
16.90%-4.46%Net Income/Loss
$15.20
210.30
111.20
109.80
83.60
137.40
220.70
519.00
-256.00
-146.00
-1066.00
-630.14%Depreciation & Amortization
$142.90
140.80
140.60
146.50
190.10
228.60
253.70
378.00
422.00
314.00
369.00
14.49%17.52%Increase/Decrease in Working Capital
$2.20
209.00
117.00
13.10
-44.20
175.40
118.90
598.00
415.00
470.00
131.00
92.51%-72.13%Share-based Compensation
$4.50
9.00
10.80
20.90
27.20
33.30
48.10
54.00
35.00
35.00
52.00
29.23%48.57%Adjustments to Reconcile Net Income
$162.30
-38.50
44.10
189.70
290.90
110.30
219.60
-80.00
510.00
204.00
1120.00
15.39%449.02%Net Cash (Operating)
$178.30
171.80
155.30
299.50
374.50
247.70
440.30
439.00
254.00
58.00
54.00
4.52%-6.90%Capital Expenditure
$175.20
271.80
137.70
309.00
919.30
1508.60
1204.40
1859.00
1042.00
921.00
251.00
24.97%-72.75%Net Cash (Investing)
$-171.20
-271.80
-137.70
-309.00
-919.30
-1510.40
-827.50
-1884.00
-955.00
-834.00
-253.00
69.66%Increase/Decrease in Debt
$-35.10
-729.40
-16.30
173.10
420.60
148.90
48.30
1022.00
485.00
539.00
89.00
-83.49%Increase/Decrease in Equity
$0.20
938.50
-6.40
262.20
420.80
1021.40
11.00
-7.00
Interest Expenses
$153.80
107.10
82.40
80.80
83.20
102.50
98.40
116.00
188.00
145.00
182.00
2.54%25.52%Dividends Paid
$
Net Cash (Financing)
$-42.10
196.50
-30.80
161.30
669.10
1201.40
1001.70
1031.00
521.00
572.00
84.00
-85.31%Cash Taxes Paid
$21.00
34.00
40.60
39.80
23.90
42.20
43.40
53.00
99.00
83.00
64.00
21.39%-22.89%Effect of Exchange Rate
$3.00
-19.60
-6.50
4.90
-2.40
-3.50
-6.70
-33.00
11.00
7.00
-3.00
17.63%-142.86%Increase/Decrease in Cash
$-32.00
76.90
-19.70
156.70
121.90
-64.80
-447.00
-169.00
-197.00
-118.00
40.10%Cash (Beginning)
$106.40
74.40
151.30
131.60
288.30
410.20
345.40
896.00
449.00
449.00
280.00
19.72%-37.64%Cash (Ending)
$74.40
151.30
131.60
288.30
410.20
345.40
953.20
449.00
280.00
252.00
162.00
18.02%-35.71%NOPAT
$165.84
485.61
156.77
165.46
228.47
201.79
328.67
689.77
-203.99
-41.26
-803.62
-1847.67%Gross Margin %
35.96%
35.65%
33.39%
32.97%
32.00%
31.97%
31.78%
33.97%
24.40%
25.72%
18.47%
Operating Margin %
14.47%
15.06%
12.38%
11.80%
11.53%
10.88%
12.75%
15.66%
-3.82%
-1.15%
-27.76%
NOPAT Margin %
9.96%
28.14%
8.91%
8.33%
9.71%
8.01%
10.62%
14.29%
-4.79%
-1.29%
-26.09%
Net Margin %
0.97%
12.30%
6.34%
5.53%
3.55%
5.46%
7.13%
10.75%
-6.01%
-4.55%
-34.61%
Tax Rate %
31.16%
-86.84%
28.02%
29.35%
15.72%
26.33%
16.67%
8.76%
-25.15%
-11.52%
6.01%
ROA
5.37%
15.44%
5.07%
4.79%
5.04%
3.26%
4.23%
6.56%
-1.89%
-0.19%
-3.94%
ROE
-44.61%
76.59%
24.65%
22.87%
21.02%
12.00%
11.34%
14.39%
-4.42%
-0.44%
-9.58%
ROIC
6.08%
17.34%
5.74%
5.55%
5.81%
3.63%
5.19%
7.43%
-2.11%
-0.45%
-9.74%
Asset Turnover
0.54
0.55
0.57
0.57
0.52
0.41
0.40
0.46
0.40
0.15
0.15
Inventory Turnover
7.91
8.36
8.14
7.68
8.18
6.66
6.52
4.54
4.15
3.20
3.38
Equity Multiplier
-8.31
4.96
4.86
4.77
4.17
3.68
2.68
2.19
2.34
2.25
2.43
Current Ratio
1.52
1.85
2.02
2.26
2.15
2.08
2.57
2.72
1.76
2.19
2.58
Quick Ratio
1.06
1.31
1.40
1.66
1.67
1.58
2.01
1.40
0.84
0.50
0.49
Debt/Equity Ratio
-7.29
2.98
2.93
2.87
2.50
1.76
1.04
0.88
1.05
0.51
0.59
Interest Coverage Ratio
1.57
2.43
2.64
2.90
3.26
2.67
4.01
6.52
-0.87
-0.26
-4.70
Working Capital/Sales
0.24
0.28
0.30
0.34
0.30
0.35
0.35
0.43
0.47
0.48
0.42
Dividend Payout Ratio %
Total Payout
$188.70
-102.00
98.70
-85.90
-599.60
-467.20
-971.30
-917.00
-297.00
-394.00
100.00
125.38%Payout Ratio %
113.78%
-21.00%
62.96%
-51.92%
-262.44%
-231.52%
-295.53%
-132.94%
-145.60%
-954.91%
12.44%